JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.

Gen Psychiatr

ISSN 2517-729x

1 paper in the library · 7 citations · publishing 2025

Papers

Expanded access to psychedelic treatments: comparing American and Canadian policies.

Gen Psychiatr February 19, 2025 Jérémie Richard, Albert Garcia‐romeu, Jack E Henningfield 7 citations

The FDA's August 2024 decision that an additional phase III study is needed before considering approval of midomafetamine for PTSD may postpone the potential approval of this treatment by several years.

DOI: 10.1136/gpsych-2024-101894 Full text Psychedelic access Psychedelic policy Compassionate use